Teva Pharmaceutical Industries Limited (TLV:TEVA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
6,640.00
+200.00 (3.11%)
Oct 5, 2025, 3:49 PM IDT

TLV:TEVA Revenue

Teva Pharmaceutical Industries had revenue of $4.18B USD in the quarter ending June 30, 2025, with 0.29% growth. This brings the company's revenue in the last twelve months to $16.63B, up 2.07% year-over-year. In the year 2024, Teva Pharmaceutical Industries had annual revenue of $16.54B with 4.40% growth.

Revenue (ttm)
$16.63B
Revenue Growth
+2.07%
P/S Ratio
1.36
Revenue / Employee
$465.95K
Employees
35,686
Market Cap
75.93B ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202416.54B698.00M4.40%
Dec 31, 202315.85B921.00M6.17%
Dec 31, 202214.93B-953.00M-6.00%
Dec 31, 202115.88B-781.00M-4.69%
Dec 31, 202016.66B-228.00M-1.35%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Danel (Adir Yeoshua)2.84B
Kamada571.15M
Bait Bakfar106.25M
BrainsWay155.27M
SofWave Medical234.12M
Ilex Medical927.57M
Novolog (Pharm-Up 1966)2.04B
InterCure238.85M
Revenue Rankings